Stock listing
NASDAQ:CBST Cubist Pharmaceuticals Inc Stock
Follow Cubist Pharmaceuticals Inc into a list and get an email when it puts out news.
Last close · NASDAQ:CBST
$101.94 USD
Close on Jan 21, 2015 · No longer trades
- Lowest – highest close
- $2.94 – $101.94 USDSince Jan 4, 1999 · lowest Mar 12, 1999 · highest Jan 21, 2015
Delisted NASDAQ:CBST no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:CBST
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Cubist Pharmaceuticals Inc on 6ix
- Decks
- 7 decks · latest Jul 26, 2005
Where Cubist Pharmaceuticals Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CBST · This page · Delisted | NASDAQ | United States | USD |
| NASDAQ:CBSTZ · Delisted | NASDAQ | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2005 Earnings Presentation | Earnings | 20 slides | Jul 26, 2005 |
| Q1 2005 Earnings Presentation | Earnings | 21 slides | Apr 22, 2005 |
| FY2004 Earnings Presentation | Earnings | 22 slides | Jan 28, 2005 |
| FY2004 Earnings Presentation | Earnings | 26 slides | Jan 18, 2005 |
| Q3 2004 Earnings Presentation | Earnings | 18 slides | Nov 2, 2004 |
| Q2 2004 Earnings Presentation | Earnings | 12 slides | Aug 9, 2004 |
| Investor Presentation (May 2004) | Investor deck | 13 slides | May 10, 2004 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert J Perez Other companies: Rapport Therapeutics, Inc. (Director · Since at least Nov 7, 2024); Immunocore Holdings plc (Director · Jan 2, 2024 – Jan 2, 2024 · Past); Third Harmonic Bio Inc. (Director · Sep 14, 2022 – Mar 6, 2023 · Past); Vir Biotechnology, Inc. (Director · Oct 10, 2019 – May 22, 2023 · Past); Cogent Biosciences, Inc. (Director · Mar 28, 2018 – Jun 14, 2019 · Past); Spark Therapeutics Inc (Director · Jan 3, 2018 – Dec 17, 2019 · Past); Larimar Therapeutics, Inc. (Director · Sep 24, 2015 – Jun 26, 2019 · Past); Decoy Therapeutics Inc. (Director · Sep 2, 2015 – Jul 26, 2017 · Past); Cidara Therapeutics Inc (Director · Apr 14, 2015 – Jun 22, 2017 · Past); AMAG Pharmaceuticals Inc (Director · Jan 26, 2009 – May 16, 2019 · Past) | Chief Executive Officer, Director · Jan 3, 2006 – Jan 21, 2015 · Past |
| Kenneth Bate Other companies: Madrigal Pharmaceuticals, Inc. (Director · Since at least Jul 22, 2016); Astria Therapeutics Inc (Director · Since at least Jun 24, 2015); Vanda Pharmaceuticals Inc. (Director · Dec 17, 2015 – Jun 15, 2017 · Past); Epizyme Inc (Director · Dec 10, 2014 – Aug 12, 2022 · Past); BioMarin Pharmaceutical Inc. (Director · Sep 22, 2010 – Jun 10, 2015 · Past); AVEO Pharmaceuticals Inc (Director · Mar 11, 2010 – Jan 19, 2023 · Past); Coley Pharmaceutical Group Inc (Director · Jun 21, 2006 – Jan 4, 2008 · Past); Nitromed Inc (President & CEO, Director · Mar 20, 2006 – Apr 24, 2009 · Past) | Director · Jun 8, 2006 – Jan 21, 2015 · Past |
| David McGirr Other companies: X4 Pharmaceuticals, Inc. (Director · Since at least Nov 15, 2017); Rhythm Pharmaceuticals, Inc. (Director · Since at least Oct 4, 2017); Insmed Incorporated (Director · Since at least Oct 30, 2013); Roka Bioscience Inc (Director · Jul 16, 2014 – Jun 28, 2017 · Past); Relypsa Inc (Director · Nov 14, 2013 – Sep 1, 2016 · Past) | SVP & Chief Financial Officer · Mar 31, 2010 – Feb 15, 2013 · Past |
| Nancy J Hutson Other companies: BioCryst Pharmaceuticals, Inc. (Director · Since at least Jan 20, 2012); Clearside Biomedical Inc (Director · Apr 21, 2020 – Jun 20, 2024 · Past); PhaseBio Pharmaceuticals Inc (Director · Oct 17, 2018 – May 19, 2023 · Past); Endo International PLC (Director · Feb 28, 2014 – Jun 11, 2021 · Past); Inspire Pharmaceuticals Inc (Director · Oct 27, 2006 – May 13, 2011 · Past) | Director · Jun 12, 2008 – Jan 21, 2015 · Past |
| Tamara L Joseph Other companies: Spero Therapeutics, Inc. (Chief Legal Officer · Dec 2, 2020 – Feb 1, 2024 · Past); Tempest Therapeutics, Inc. (General Counsel and Secretary · Aug 19, 2019 – May 25, 2020 · Past); InVivo Therapeutics Holdings Corp (SVP, General Counsel · Mar 24, 2014 – Jan 18, 2017 · Past) | SVP, GC & Secretary · Apr 30, 2008 – Jun 29, 2012 · Past |
| Thomas J. DesRosier Other companies: Seres Therapeutics, Inc. (EVP, Chief Legal Officer · Since at least May 16, 2016); Ariad Pharmaceuticals Inc (EVP, General Counsel · Jan 26, 2015 – Mar 7, 2016 · Past); Genzyme Corp (Sr VP, General Counsel · May 22, 2008 – Apr 4, 2011 · Past) | SVP, Chief Legal Officer & GC · Mar 18, 2013 – Feb 14, 2014 · Past |
| Charles Anthony Laranjeira Other companies: Pacira BioSciences, Inc. (Chief Technical Officer · Jun 13, 2018 – Jun 14, 2022 · Past) | SVP, Technical Operations · Jun 27, 2011 – May 20, 2013 · Past |
| Gregory Stea Other companies: Achaogen Inc (Director · Jun 10, 2015 – Jun 5, 2018 · Past) | SVP, Commercial Operations · Feb 12, 2009 – Sep 30, 2014 · Past |
| Michael B Wood Other companies: STERIS plc (Ireland) (Director · Aug 2, 2006 – May 16, 2019 · Past) | Director · Feb 13, 2006 – Jun 12, 2013 · Past |
| Francis P Tally | Senior Vice President · Jan 9, 2006 – Sep 29, 2006 · Past |
All 11 people
| Person | Seat |
|---|---|
| Martin Rosenberg | Director · Jun 6, 2013 – Sep 9, 2013 · Past |
Log in to ask 6ix AI your own questions about Cubist Pharmaceuticals Inc.